Luminate
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Luminate, covering 2017-12-15 to 2020-07-08. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial Designed To Evaluate The Safety And Exploratory Efficacy Of 1.0 Mg Luminate® (Alg-1001) As A Treatment For Non-Exudative Macular Degeneration [Phase 2]